Christine Toulas

Christine Toulas

UNVERIFIED PROFILE

Are you Christine Toulas?   Register this Author

Register author
Christine Toulas

Christine Toulas

Publications by authors named "Christine Toulas"

Are you Christine Toulas?   Register this Author

40Publications

800Reads

6Profile Views

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker.

Oncotarget 2018 Aug 3;9(60):31637-31649. Epub 2018 Aug 3.

Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1037/Université Toulouse III Paul Sabatier, Cancer Research Center of Toulouse (CRCT), Toulouse, F-31000, France.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/25827
Publisher Site
http://dx.doi.org/10.18632/oncotarget.25827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114977PMC
August 2018

Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.

Clin Lung Cancer 2018 05 21;19(3):e277-e285. Epub 2017 Nov 21.

Department of Radiation Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France; Université Paul Sabatier, Toulouse, France; INSERM U1037, Centre de Recherche Contre le Cancer de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.11.002DOI Listing
May 2018

By modulating α2β1 integrin signalling, gastrin increases adhesion oF AGS-GR gastric cancer cells.

Exp Cell Res 2018 01 15;362(2):498-503. Epub 2017 Dec 15.

INSERM UMR.1037-Cancer Research Center of Toulouse (CRCT)/University Paul Sabatier Toulouse III, team 11, Oncopole 2 Avenue Hubert Curien, CS 53717, 31037 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2017.12.014DOI Listing
January 2018

Targeting progastrin enhances radiosensitization of colorectal cancer cells.

Oncotarget 2017 Aug 20;8(35):58587-58600. Epub 2017 Apr 20.

Cancer Research Center of Toulouse (CRCT), UMR1037 Inserm/University Toulouse III Paul Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.17274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601677PMC
August 2017

FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α Pathway.

Cancer Res 2016 05 19;76(10):3036-44. Epub 2016 Feb 19.

Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1037/Université Toulouse III Paul Sabatier, Cancer Research Center of Toulouse (CRCT), Team 11, Toulouse, France. Institut Claudius Regaud, IUCT-O, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-2058DOI Listing
May 2016

Preclinical evidence that SSR128129E--a novel small-molecule multi-fibroblast growth factor receptor blocker--radiosensitises human glioblastoma.

Eur J Cancer 2014 Sep 18;50(13):2351-9. Epub 2014 Jun 18.

Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse F-31000, France; Institut Claudius Regaud, Toulouse F-31000, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.05.012DOI Listing
September 2014

Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.

Int J Mol Sci 2014 Jan 29;15(2):2172-90. Epub 2014 Jan 29.

INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms15022172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958844PMC
January 2014

Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1 alpha and survivin in U87 cells.

Eur J Cancer 2013 Sep 6;49(13):2884-91. Epub 2013 Jun 6.

Institut National de Santé et de Recherche Médicale (INSERM), UMR 1037, Cancer Research Center of Toulouse, Toulouse F-31000, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.05.003DOI Listing
September 2013

Simplified identification of Lynch syndrome: a prospective, multicenter study.

Dig Liver Dis 2012 Jun 3;44(6):515-22. Epub 2012 Apr 3.

Purpan Hospital, Medical Oncology, Institut Claudius Regaud, Medical Genetics, Cancer Research Centre of Toulouse, INSERM UMR 1037/CNRS-ERL 5294/Toulouse 3 University, Markers & Targets for Digestive Cancer Biotherapy, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2011.12.020DOI Listing
June 2012

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Cancer Epidemiol Biomarkers Prev 2010 Nov 26;19(11):2859-68. Epub 2010 Oct 26.

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077716PMC
November 2010

The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding.

Breast Cancer Res Treat 2010 Apr 30;120(2):391-9. Epub 2009 Apr 30.

INSERM U563, Institut Claudius Regaud, 20-24 rue du Pont St Pierre, 31052, Toulouse, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-009-0392-3
Publisher Site
http://dx.doi.org/10.1007/s10549-009-0392-3DOI Listing
April 2010

Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.

Cancer Res 2009 Apr 7;69(8):3308-16. Epub 2009 Apr 7.

Institut National de la Santé et de la Recherche Médicale (INSERM) U563, Department of Signaling, Oncogenesis, and Therapeutic Innovation, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-2158DOI Listing
April 2009

Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.

Int J Cancer 2008 Jul;123(2):357-364

Institut Claudius Regaud, INSERMU563, Department of Oncogenesis, Signalling and Therapeutic Innovation, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.23498DOI Listing
July 2008

Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells.

Cancer Res 2006 Jan;66(1):482-9

Institut National de la Sante et de la Recherche Medicale U563, Departement d'Innovation Thérapeutique et Oncologie Moléculaire, Centre de Lutte Contre le Cancer Claudius Regaud, Toulouse Cedex, France.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-05-2299DOI Listing
January 2006

Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts.

Oncogene 2003 Dec;22(55):8861-9

Département Innovation Thérapeutique et Oncologie Moléculaire INSERM U563, Institut Claudius Regaud, 20-24 rue du Pont St Pierre, 31052 Toulouse Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207095DOI Listing
December 2003

The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.

Clin Cancer Res 2003 Dec;9(16 Pt 1):6062-8

Laboratoire d'Oncologie Cellulaire et Moléculaire Institut National de la Santé et de la Recherche Médicale U593, Institut Claudius Regaud, Toulouse Cedex, France.

View Article

Download full-text PDF

Source
December 2003

Two prognostic groups of inflammatory breast cancer have distinct genotypes.

Clin Cancer Res 2003 Sep;9(11):4184-9

Institut National de la Santé et de la Recherche Médicale (INSERM) E0017/Oncogénétique, Centre René Huguenin, 35 rue Dailly, F-92211 St-Cloud, France.

View Article

Download full-text PDF

Source
September 2003

RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death.

Oncogene 2002 Sep;21(39):5998-6006

Oncologie Cellulaire et Moléculaire, INSERM U563, Département d'Innovation thérapeutique et Oncologie Moléculaire, Centre de Lutte Contre le Cancer Claudius Regaud, 20-24 rue du Pont St Pierre, 31052 Toulouse Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205746DOI Listing
September 2002

The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit.

Oncogene 2002 Sep;21(42):6471-9

Oncologie Cellulaire et Moléculaire, INSERM U563, Département d'Innovation thérapeutique et Oncologie Moléculaire, Centre de Lutte Contre le Cancer Claudius Regaud, 20-24 rue du Pont St Pierre, 31052 Toulouse Cedex France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205838DOI Listing
September 2002

Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation.

Int J Cancer 2002 Jul;100(1):43-8

Laboratoire d'Oncologie Cellulaire et Moléculaire, Centre de Lutte Contre le Cancer Claudius Regaud, Toulouse Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10439DOI Listing
July 2002